M. Şendur

Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

A. Alkan, H. Turna, E. Esin, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

A. Alkan, H. Turna, E. Esin, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?

B. Öksüzoğlu, H. Turna, A. Sezer, 2019, Journal of Oncology Pharmacy Practice.